Chemours
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $1,540,000 | $1,591,000 | $1,381,000 | $1,330,000 |
Gross Profit | 231,000 | 286,000 | 215,000 | 153,000 |
EBITDA | 182,000 | -413,000 | 125,000 | -76,000 |
EBIT | -493,000 | 46,000 | -76,000 | |
Net Income | 196,000 | -274,000 | -29,000 | -61,000 |
Net Change In Cash | 1,540,000 | 1,591,000 | 1,381,000 | 1,330,000 |
Free Cash Flow | 191,000 | 114,000 | -93,000 | 92,000 |
Cash | 698,000 | 671,000 | 563,000 | 670,000 |
Basic Shares | 151,381 | 150,550 | 150,550 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $5,808,000 | $5,782,000 | $6,078,000 | $6,831,000 |
Gross Profit | 902,000 | 1,151,000 | 1,306,000 | 1,616,000 |
EBITDA | 332,000 | 692,000 | 197,000 | 1,195,000 |
EBIT | -8,000 | 391,000 | -110,000 | 904,000 |
Net Income | -386,000 | 86,000 | -238,000 | 578,000 |
Net Change In Cash | 5,808,000 | 5,782,000 | 6,078,000 | 6,831,000 |
Cost of Revenue | -215,000 | |||
Free Cash Flow | 51,000 | -993,000 | 186,000 | 447,000 |
Cash | 672,000 | 713,000 | 1,203,000 | 1,102,000 |
Basic Shares | 150,550 | 150,014 | 148,912 | 158,303 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | $0.21 |
2026-06-30 | $0.42 |
2026-03-31 | $0.05 |
2025-12-31 | $0.05 |